| Acquirer | Target | Price |
|---|---|---|
| Novartis AG | Cerulean’s Dynamic Tumor Targeting platform | $6 million |
| JPB Capital Partners | Hometown Hospice and Homecare, Inc. | N/A |
| Daré Bioscience | Cerulean Pharma Inc. | Merger |
| Alliar | Multiscan Imagem e Diagnostico | $29.3 million |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
